Research on the Molecular Mechanism of PRPF19 in Regulating the Growth and Metastasis of Pancreatic Cancer Cells
Аннотация
Abstract Objective To explore the molecular mechanisms by which PRPF19 regulates the growth and metastasis‑associated cellular phenotypes of pancreatic cancer cells. Methods Bioinformatic analyses were performed as follows: using the Sangerbox and UALCAN databases to compare PRPF19 between pancreatic cancer tissues and normal pancreatic tissues, Immunohistochemical data for PRPF19 in pancreatic cancer tissues were retrieved from the HPA database, and using the CHIPBASE 3.0 database to predict the interacting molecules of PRPF19 and their correlation. The expression levels of PRPF19 protein and mRNA in pancreatic cancer cells were detected by Western blot and quantitative real-time polymerase chain reaction (qRT-PCR), respectively. Western blot was further used to determine the changes in the expression of key pathway-related proteins in the pathway after knocking down PRPF19 and the molecular-level changes after applying pathway agonists. The small interfering RNA (siRNA) technology was used to knock down the expression of PRPF19 in pancreatic cancer cells, and the knockdown efficiency was verified by Western blot and qRT-PCR. Cell Counting Kit-8 (CCK-8), colony formation, and Transwell assays were performed to evaluate the effects of knocking down PRPF19 on the proliferation, colony‑forming capacity, migration, and invasion abilities of pancreatic cancer cells. Hoechst staining was used to detect upon PRPF19 knockdown. Pathway agonists were applied to further utilized to dissect the signaling pathway mediating PRPF19 function, so as to clarify the molecular mechanism underlying its regulation of pancreatic cancer cell biological behaviors. Results The analysis of bioinformatics results revealed that PRPF19 is overexpressed in most tumors types. Specifically, compared with normal pancreatic tissues, PRPF19 is highly expressed in pancreatic cancer tissues. Consistently, elevated PRPF19 levels were observed in multiple pancreatic cancer cell lines including MIA PaCa‑2 and PANC‑1 compared with normal pancreatic cells (P < 0.05). Upon PRPF19 knockdown, pancreatic cancer cells exhibited markedly reduced proliferation rates, fewer colonies, weakened migratory and invasive capacities, and increased apoptotic cell numbers relative to control cells ( P < 0.05). Both bioinformatic prediction and cellular experiments confirmed that PRPF19 modulates multiple biological behaviors of pancreatic cancer cells through the YAP signaling pathway. Conclusion PRPF19 modulates the proliferation and metastasis‑associated cellular phenotypes of pancreatic cancer cells via the YAP signaling pathway.